Some patients stay on a lower maintenance dose long term, which is also a reasonable choice
Instead of mimicking gut hormones like GLP-1 medications or following a daily weight loss injection plan, it targets pathways that regulate fat storage, energy expenditure, and insulin sensitivity
(PubMed) Eshak ES, Iso H, Yamagishi K, Cui R, Tamakoshi A
(12) This is because the use of both medications has not been studied, so it is unclear if the combination is safe
[119] conducted a phase II clinical trial in patients with NASH, that is, a placebo-controlled trial of subcutaneous sommarutide in the treatment of NASH, and found that sommarutide treatment resulted in a significantly higher proportion of patients in remission of NASH compared with placebo